TrialEuropean urology focus2018

A Randomized, Double-blind, Phase II Trial of PSA-TRICOM (PROSTVAC) in Patients with Localized Prostate Cancer: The Immunotherapy to Prevent Progression on Active Surveillance Study.

J Kellogg Parsons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.